Maximilian Larena
Maximilian Larena
Verified email at ebc.uu.se
Title
Cited by
Cited by
Year
Pivotal Role of Antibody and Subsidiary Contribution of CD8+ T Cells to Recovery from Infection in a Murine Model of Japanese Encephalitis
M Larena, M Regner, E Lee, M Lobigs
Journal of virology 85 (11), 5446-5455, 2011
732011
An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile …
N Petrovsky, M Larena, V Siddharthan, NA Prow, RA Hall, M Lobigs, ...
Journal of virology 87 (18), 10324-10333, 2013
602013
JE-ADVAX Vaccine Protection against Japanese Encephalitis Virus Mediated by Memory B Cells in the Absence of CD8+ T Cells and Pre-Exposure Neutralizing …
M Larena, NA Prow, RA Hall, N Petrovsky, M Lobigs
Journal of virology 87 (8), 4395-4402, 2013
592013
Live chimeric and inactivated Japanese encephalitis virus vaccines differ in their cross-protective values against Murray Valley encephalitis virus
M Lobigs, M Larena, M Alsharifi, E Lee, M Pavy
Journal of virology 83 (6), 2436-2445, 2009
542009
Cholera toxin, and the related nontoxic adjuvants mmCT and dmLT, promote human Th17 responses via cyclic AMP–protein kinase A and inflammasome-dependent IL-1 signaling
M Larena, J Holmgren, M Lebens, M Terrinoni, A Lundgren
The Journal of Immunology 194 (8), 3829-3839, 2015
532015
Cytolytic effector pathways and IFN‐γ help protect against J apanese encephalitis
M Larena, M Regner, M Lobigs
European journal of immunology 43 (7), 1789-1798, 2013
392013
The chemokine receptor CCR5, a therapeutic target for HIV/AIDS antagonists, is critical for recovery in a mouse model of Japanese encephalitis
M Larena, M Regner, M Lobigs
PLoS One 7 (9), e44834, 2012
292012
Construction and preclinical evaluation of mmCT, a novel mutant cholera toxin adjuvant that can be efficiently produced in genetically manipulated Vibrio cholerae
M Lebens, M Terrinoni, SL Karlsson, M Larena, T Gustafsson-Hedberg, ...
Vaccine 34 (18), 2121-2128, 2016
272016
Deficiency in calcium-binding protein S100A4 impairs the adjuvant action of cholera toxin
JB Sun, J Holmgren, M Larena, M Terrinoni, Y Fang, AR Bresnick, Z Xiang
Frontiers in immunology 8, 1119, 2017
82017
Immunobiology of Japanese encephalitis virus
M Larena, M Lobigs
Flavivirus Encephalitis 317, 338, 2011
82011
Internal ribosome entry site-based attenuation of a flavivirus candidate vaccine and evaluation of the effect of beta interferon coexpression on vaccine properties
M Frese, E Lee, M Larena, PS Lim, S Rao, KI Matthaei, A Khromykh, ...
Journal of virology 88 (4), 2056-2070, 2014
72014
Proteomic analysis of cholera toxin adjuvant-stimulated human monocytes identifies Thrombospondin-1 and Integrin-β1 as strongly upregulated molecules involved in adjuvant activity
M Terrinoni, J Holmgren, M Lebens, M Larena
Scientific reports 9 (1), 1-13, 2019
42019
Requirement for cyclic AMP/protein kinase A-dependent canonical NFκB signaling in the adjuvant action of cholera toxin and its non-toxic derivative mmCT
M Terrinoni, J Holmgren, M Lebens, M Larena
Frontiers in immunology 10, 269, 2019
42019
Partial dysfunction of STAT1 profoundly reduces host resistance to flaviviral infection
M Larena, M Lobigs
Virology 506, 1-6, 2017
42017
Genomic insights into population history and biological adaptation in Oceania
J Choin, J Mendoza-Revilla, LR Arauna, S Cuadros-Espinoza, O Cassar, ...
Nature 592 (7855), 583-589, 2021
32021
Multiple migrations to the Philippines during the last 50,000 years
M Larena, F Sanchez-Quinto, P Sjödin, J McKenna, C Ebeo, R Reyes, ...
Proceedings of the National Academy of Sciences 118 (13), 2021
22021
The system can't perform the operation now. Try again later.
Articles 1–16